27605 Clinical Research Hamburg GmbH
Welcome,         Profile    Billing    Logout  
 2 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grigat, Christine
NCT06015282: The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

Completed
3
7741
Europe, Canada, US, RoW
Investigational aQIVc, licensed QIV1, licensed QIV2
Seqirus
Influenza, Human
03/24
01/25
NCT05371080 / 2021-005319-30: A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Active, not recruiting
3
3038
Europe, Canada, Japan, US, RoW
HZ/su vaccine
GlaxoSmithKline
Herpes Zoster
08/27
08/27
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
NCT05077267 / 2021-001393-31: ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Completed
2
197
Europe
ABNCoV2 100ug, ABNCoV2 50ug
Bavarian Nordic, Bavarian Nordic A/S
COVID-19 Disease
02/22
10/23
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Active, not recruiting
2
464
Europe, RoW
Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo
Chiesi Farmaceutici S.p.A.
Uncontrolled Asthma
03/26
02/27
NCT05561673 / 2021-005629-25: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Completed
1/2
122
Europe
GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, Engerix-B, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, Fendrix, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2
GlaxoSmithKline, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Hepatitis B
11/24
11/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grigat, Christine
NCT06015282: The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

Completed
3
7741
Europe, Canada, US, RoW
Investigational aQIVc, licensed QIV1, licensed QIV2
Seqirus
Influenza, Human
03/24
01/25
NCT05371080 / 2021-005319-30: A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults

Active, not recruiting
3
3038
Europe, Canada, Japan, US, RoW
HZ/su vaccine
GlaxoSmithKline
Herpes Zoster
08/27
08/27
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
NCT05077267 / 2021-001393-31: ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

Completed
2
197
Europe
ABNCoV2 100ug, ABNCoV2 50ug
Bavarian Nordic, Bavarian Nordic A/S
COVID-19 Disease
02/22
10/23
TANGO, NCT06029595: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy

Active, not recruiting
2
464
Europe, RoW
Experimental: CHF6001 3200 μg, Placebo Comparator: CHF6001 Placebo
Chiesi Farmaceutici S.p.A.
Uncontrolled Asthma
03/26
02/27
NCT05561673 / 2021-005629-25: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Completed
1/2
122
Europe
GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, Engerix-B, GSK's HBsAg candidate vaccine adjuvanted with GSK's AS03 adjuvant system, GSK's Hepatitis B vaccine adjuvanted with GSK's AS04 adjuvant system, Fendrix, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 1, GSK's HBsAg vaccine adjuvanted with GSK's AS37 adjuvant system formulation 2
GlaxoSmithKline, GlaxoSmithKline Biologicals, GlaxoSmithKline Biologicals SA
Hepatitis B
11/24
11/24

Download Options